[1] |
CIOCCA M, ÁLVAREZ F. Neonatal acute liver failure: A diagnosis challenge[J]. Arch Argent Pediatr, 2017, 115(2): 175-180. DOI: 10.5546/aap.2017.eng.175.
|
[2] |
KARADAǦ N, OKBAY GÜNEŞ A, KARATEKIN G. Acute liver failure in newborns[J]. Turk Arch Pediatr, 2021, 56(2): 108-114. DOI: 10.5152/TurkArchPediatr.2021.190205.
|
[3] |
TAYLOR SA, WHITINGTON PF. Neonatal acute liver failure[J]. Liver Transpl, 2016, 22(5): 677-685. DOI: 10.1002/lt.24433.
|
[4] |
SHANMUGAM NP, BANSAL S, GREENOUGH A, et al. Neonatal liver failure: Aetiologies and management-state of the art[J]. Eur J Pediatr, 2011, 170(5): 573-581. DOI: 10.1007/s00431-010-1309-1.
|
[5] |
ZOZAYA NIETO C, FERNÁNDEZ CAAMAÑO B, MUÑOZ BARTOLO G, et al. Presenting features and prognosis of ischemic and nonischemic neonatal liver failure[J]. J Pediatr Gastroenterol Nutr, 2017, 64(5): 754-759. DOI: 10.1097/MPG.0000000000001501.
|
[6] |
CASAS-ALBA D, CLOTET J, INAREJOS EJ, et al. Broadening the spectrum of neonatal hemochromatosis[J]. J Matern Fetal Neonatal Med, 2020, 33(6): 1024-1026. DOI: 10.1080/14767058.2018.1506442.
|
[7] |
BERSANI I, AURITI C, PIERSIGILLI F, et al. Neonatal acute liver failure due to enteroviruses: A 14 years single NICU experience[J]. J Matern Fetal Neonatal Med, 2020, 33(15): 2576-2580. DOI: 10.1080/14767058.2018.1555806.
|
[8] |
DEMIRBAS D, COELHO AI, RUBIO-GOZALBO ME, et al. Hereditary galactosemia[J]. Metabolism, 2018, 83: 188-196. DOI: 10.1016/j.metabol.2018.01.025.
|
[9] |
LI H, BYERS HM, DIAZ-KUAN A, et al. Acute liver failure in neonates with undiagnosed hereditary fructose intolerance due to exposure from widely available infant formulas[J]. Mol Genet Metab, 2018, 123(4): 428-432. DOI: 10.1016/j.ymgme.2018.02.016.
|
[10] |
AKTUGLU-ZEYBEK AC, KIYKIM E, CANSEVER MS. Hereditary tyrosinemia type 1 in Turkey[J]. Adv Exp Med Biol, 2017, 959: 157-172. DOI: 10.1007/978-3-319-55780-9_15.
|
[11] |
KANUNGO S, MORTON J, NEELAKANTAN M, et al. Mitochondrial disorders[J]. Ann Transl Med, 2018, 6(24): 475. DOI: 10.21037/atm.2018.12.13.
|
[12] |
MOREIRA-SILVA H, MAIO I, BANDEIRA A, et al. Metabolic liver diseases presenting with neonatal cholestasis: At the crossroad between old and new paradigms[J]. Eur J Pediatr, 2019, 178(4): 515-523. DOI: 10.1007/s00431-019-03328-5.
|
[13] |
CAPPELL MS, HADER I, AMIN M. Acute liver failure secondary to severe systemic disease from fatal hemophagocytic lymphohistiocytosis: Case report and systematic literature review[J]. World J Hepatol, 2018, 10(9): 629-636. DOI: 10.4254/wjh.v10.i9.629.
|
[14] |
HEISSAT S, COLLARDEAU-FRACHON S, BARUTEAU J, et al. Neonatal hemochromatosis: Diagnostic work-up based on a series of 56 cases of fetal death and neonatal liver failure[J]. J Pediatr, 2015, 166(1): 66-73. DOI: 10.1016/j.jpeds.2014.09.030.
|
[15] |
FACCIORUSSO A, CHANDAR AK, MURAD MH, et al. Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: A systematic review and network meta-analysis[J]. Lancet Gastroenterol Hepatol, 2017, 2(2): 94-102. DOI: 10.1016/S2468-1253(16)30157-1.
|
[16] |
ALOBAIDI R, ANTON N, CAVE D, et al. Predicting early outcomes of liver transplantation in young children: The EARLY study[J]. World J Hepatol, 2018, 10(1): 62-72. DOI: 10.4254/wjh.v10.i1.62.
|
[17] |
SUNDARAM SS, ALONSO EM, ANAND R, et al. Outcomes after liver transplantation in young infants[J]. J Pediatr Gastroenterol Nutr, 2008, 47(4): 486-492. DOI: 10.1097/MPG.0b013e318175d7d2.
|